|
Zydus Lifesciences Ltd.
|
Nine Months RESULTS
|
|
|
You can view the
Nine Months Results
for the last 5 years.
|
Market Cap. (Rs.)
|
119842.47 Cr.
|
P/BV
|
4.42
|
Book Value (Rs.)
|
269.43
|
|
52 Week High/Low (Rs.)
|
1182/836
|
FV/ML
|
1/1
|
P/E(X)
|
23.78
|
|
Bookclosure
|
24/07/2026
|
EPS (Rs.)
|
50.09
|
Div Yield (%)
|
0.08
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 19285.30 | 16283.60 | 14013.60 | 12569.70 | 11465.20 |
| Other Operating Income | 276.10 | 430.00 | 0.00 | 0.00 | 0.00 |
| Total Income From Operations | 19561.40 | 16713.60 | 14013.60 | 12569.70 | 11465.20 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 3762.40 | 3208.50 | 3370.20 | 2912.90 | 3010.90 |
| Purchase of Traded Goods | 2098.80 | 1577.40 | 1355.00 | 1465.90 | 1335.80 |
| Increase/Decrease in Stocks | -544.90 | -145.00 | -108.50 | 235.30 | -242.30 |
| Employees Cost | 3179.10 | 2709.20 | 2300.60 | 2041.70 | 1887.40 |
| Depreciation | 899.60 | 677.90 | 558.80 | 544.10 | 550.70 |
| Other Expenses | 5145.30 | 4430.50 | 3342.50 | 3309.60 | 2927.10 |
| Total Expenses | 14540.30 | 12458.50 | 10818.60 | 10509.50 | 9469.60 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 5021.10 | 4255.10 | 3195.00 | 2060.20 | 1995.60 |
| Other Income | 375.30 | 188.90 | 127.70 | 148.80 | 145.70 |
| P/L Before Interest, Excpt. Items & Tax | 5396.40 | 4444.00 | 3322.70 | 2209.00 | 2141.30 |
| Interest | 315.90 | 89.30 | 46.60 | 102.20 | 88.50 |
| P/L Before Exceptional Items & Tax | 5080.50 | 4354.70 | 3276.10 | 2106.80 | 2052.80 |
| Exceptional Items | -119.10 | 0.00 | -14.20 | -2.90 | -95.70 |
| P/L Before Tax | 4961.40 | 4354.70 | 3261.90 | 2103.90 | 1957.10 |
| Tax | 1276.30 | 988.70 | 656.30 | 450.60 | 352.20 |
| P/L After Tax from Ordinary Activities | 3685.10 | 3366.00 | 2605.60 | 1653.30 | 1604.90 |
| Extra Ordinary Item | 0.00 | 0.00 | 19.80 | -2.40 | 2518.50 |
| Net Profit/Loss For the Period | 3685.10 | 3366.00 | 2625.40 | 1650.90 | 4123.40 |
| Share Of P/L Of Associates | 97.40 | 62.90 | 101.30 | 82.80 | 41.60 |
| Net P/L After Minority Interest & Share Of Associates | 3782.50 | 3428.90 | 2726.70 | 1733.70 | 4165.00 |
| | | | | | |
| Equity Share Capital | 100.60 | 100.60 | 101.20 | 101.20 | 102.40 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 36.63 | 33.34 | 26.45 | 16.36 | 39.95 |
| Diluted EPS (Rs.) | 36.63 | 33.34 | 26.45 | 16.36 | 39.95 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 36.63 | 33.34 | 26.45 | 16.36 | 39.95 |
| Diluted EPS (Rs.) | 37.60 | 33.34 | 26.45 | 16.36 | 39.95 |
| | | | | | |
| PBITOE Margin (%) | 25.66 | 25.45 | 22.79 | 16.39 | 17.40 |
| PBTE Margin (%) | 25.97 | 26.05 | 23.37 | 16.76 | 17.90 |
| PBT Margin (%) | 25.36 | 26.05 | 23.27 | 16.73 | 17.06 |
| PAT Margin (%) | 18.83 | 20.13 | 18.73 | 13.13 | 35.96 |
| PAT After MI And SOA Margin (%) | 19.33 | 20.51 | 19.45 | 13.79 | 36.32 |
